Analysen zu AXA S.A.
| 28.02.25 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.25 | AXA Kaufen | DZ BANK | |
| 27.02.25 | AXA Neutral | Goldman Sachs Group Inc. | |
| 27.02.25 | AXA Buy | UBS AG | |
| 27.02.25 | AXA Buy | Jefferies & Company Inc. | |
| 27.02.25 | AXA Overweight | JP Morgan Chase & Co. | |
| 13.02.25 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.25 | AXA Buy | Deutsche Bank AG | |
| 04.02.25 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.25 | AXA Neutral | Goldman Sachs Group Inc. | |
| 17.01.25 | AXA Overweight | JP Morgan Chase & Co. | |
| 15.01.25 | AXA Buy | Jefferies & Company Inc. | |
| 04.12.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 25.11.24 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.11.24 | AXA Overweight | Barclays Capital | |
| 08.11.24 | AXA Buy | Deutsche Bank AG | |
| 05.11.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | AXA Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | AXA Kaufen | DZ BANK | |
| 31.10.24 | AXA Buy | Deutsche Bank AG | |
| 31.10.24 | AXA Buy | Jefferies & Company Inc. | |
| 31.10.24 | AXA Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | AXA Buy | UBS AG | |
| 31.10.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 14.10.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 19.09.24 | AXA Overweight | Barclays Capital | |
| 18.09.24 | AXA Neutral | Goldman Sachs Group Inc. | |
| 04.09.24 | AXA Buy | Jefferies & Company Inc. | |
| 04.09.24 | AXA Overweight | Barclays Capital | |
| 22.08.24 | AXA Buy | UBS AG | |
| 16.08.24 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.08.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 05.08.24 | AXA Kaufen | DZ BANK | |
| 02.08.24 | AXA Buy | UBS AG | |
| 02.08.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 01.08.24 | AXA Buy | Jefferies & Company Inc. | |
| 24.07.24 | AXA Buy | UBS AG | |
| 24.07.24 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.07.24 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 18.06.24 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.06.24 | AXA Overweight | Barclays Capital | |
| 14.05.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 10.05.24 | AXA Buy | Jefferies & Company Inc. | |
| 06.05.24 | AXA Kaufen | DZ BANK | |
| 03.05.24 | AXA Buy | Deutsche Bank AG | |
| 03.05.24 | AXA Buy | Jefferies & Company Inc. | |
| 02.05.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | AXA Buy | UBS AG | |
| 02.05.24 | AXA Buy | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 10.02.26 | Richemont Outperform | Bernstein Research | |
| 10.02.26 | ING Group Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | AUMOVIO Market-Perform | Bernstein Research | |
| 10.02.26 | L'Oréal Market-Perform | Bernstein Research | |
| 10.02.26 | Scout24 Outperform | Bernstein Research | |
| 10.02.26 | Merck Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | TeamViewer Neutral | Goldman Sachs Group Inc. | |
| 10.02.26 | UniCredit Hold | Deutsche Bank AG | |
| 10.02.26 | UBS Buy | Deutsche Bank AG | |
| 10.02.26 | AUMOVIO Buy | Deutsche Bank AG | |
| 10.02.26 | Fresenius Medical Care Sell | UBS AG | |
| 10.02.26 | Fraport Sell | UBS AG | |
| 10.02.26 | AUMOVIO Buy | UBS AG | |
| 10.02.26 | Philips Buy | UBS AG | |
| 10.02.26 | Kering Neutral | UBS AG | |
| 10.02.26 | Rio Tinto Neutral | UBS AG | |
| 10.02.26 | ams-OSRAM Buy | UBS AG | |
| 10.02.26 | TUI Neutral | UBS AG | |
| 10.02.26 | AstraZeneca Buy | UBS AG | |
| 10.02.26 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.26 | grenke Buy | Warburg Research | |
| 10.02.26 | Sixt Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.26 | BP Hold | Jefferies & Company Inc. | |
| 10.02.26 | VINCI Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.26 | AstraZeneca Overweight | Barclays Capital | |
| 10.02.26 | BP Overweight | Barclays Capital | |
| 10.02.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 10.02.26 | Akzo Nobel Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | Air Liquide Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | BASF Buy | Goldman Sachs Group Inc. | |
| 10.02.26 | Philips Market-Perform | Bernstein Research | |
| 10.02.26 | TUI Buy | Deutsche Bank AG | |
| 10.02.26 | Kering Underperform | Bernstein Research | |
| 10.02.26 | TUI Market-Perform | Bernstein Research | |
| 10.02.26 | Kering Hold | Deutsche Bank AG | |
| 10.02.26 | BP Sector Perform | RBC Capital Markets | |
| 10.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 10.02.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | TUI Hold | Jefferies & Company Inc. | |
| 10.02.26 | Philips Hold | Jefferies & Company Inc. | |
| 10.02.26 | TeamViewer Neutral | JP Morgan Chase & Co. | |
| 10.02.26 | TUI Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Philips Neutral | JP Morgan Chase & Co. | |
| 10.02.26 | ams-OSRAM Underweight | JP Morgan Chase & Co. | |
| 10.02.26 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 10.02.26 | ams-OSRAM Equal Weight | Barclays Capital | |
| 10.02.26 | Philips Overweight | Barclays Capital | |
| 10.02.26 | TeamViewer Overweight | Barclays Capital | |
| 10.02.26 | Kering Underweight | Barclays Capital | |
| 10.02.26 | LANXESS Neutral | Goldman Sachs Group Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.